About Paul Johnson
Paul Johnson is a British-American entrepreneur, investor, and author based in San Francisco. He is a General Partner and the Chief Executive Officer of Flex Capital, a seed-stage venture capital firm founded in 2017 that manages more than $225 million.
Paul co-founded Lemonaid Health in 2013 and led the company as CEO. Lemonaid offered online doctor visits, prescriptions, and lab tests for a flat fee, grew to serve patients in all fifty states, and was acquired by 23andMe for $400 million in 2021. After the acquisition he served as General Manager and then Chief Operating Officer of 23andMe’s consumer business.
Before Lemonaid, Paul was UK Managing Director of the online pet retailer Zooplus and Head of Online at McKesson UK, where he was responsible for the group’s digital business including Lloyds Pharmacy. He studied computer science and business management at the University of Worcester.
Paul writes biographies of the people building artificial intelligence under the name Paul D. Johnson. His books are Move 37: The Life of Demis Hassabis and Not Insects: The Life of Geoffrey Hinton.
He is an independent non-executive director of Closed Loop Medicine, a UK precision-medicine company, and coaches chief executives of high-growth companies. He was born in Luton, England, in 1984 and became a United States citizen in 2021.
- Role
- General Partner and CEO, Flex Capital
- Based in
- San Francisco, California
- Born
- 1984, Luton, England
- Education
- University of Worcester
- Books
- Move 37 (2026), Not Insects (2026)
- Board
- Closed Loop Medicine (Non-Executive Director, since 2024)